
|Videos|May 6, 2021
A look at real-world trial data replication outcomes from IRIS Registry data
Author(s)David Hutton, OT Staff Reports
Theodore Leng, MD, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," during the virtual 2021 ARVO meeting.
Advertisement
Theodore Leng, MD, medical advisor at Verana Health and director of clinical translational research, Byers Eye Institute, Stanford University School of Medicine, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," in which the first replications using real-world data of a phase 3 trial was utilized, during the virtual 2021 ARVO meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Ophthalmic care uncommon after tamoxifen initiation
2
Training refractive surgeons and expanding access to eye surgery
3
Empire Forum 2026: Ambati on K8 phase 2 results in geographic atrophy
4
Looking beyond visual acuity in macular telangiectasia
5















